What in vitro or in vivo model should you use?

What studies should come first, second, etc.?

We can help you answer those questions. NDI has over 20 years' experience working with start-up, biotech, and both medium and large pharma companies. We have seen what approaches to pre-clinical development of CNS therapeutics work well, and which...not so much. We have the experience, and the expertise, to help guide development programs.
 

Give us a call, or write.